Schliemann C, Kessler T, Berdel AF, Hemmerle T, et al. Phase I study of F16IL2 antibody-cytokine fusion with very low-dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation. Br J Haematol 2021;192:e148-e151.
PMID: 33618424